Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
OPERATING ACTIVITIES:
Net loss	$ (4,483,341)	$ (19,433,195)
Loss from discontinued operations	(1,476,220)	(2,124,713)
Net loss from continuing operations	(3,007,121)	(17,308,482)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	223,249	389,813
Stock-based compensation	588,156	2,322,629
Bad debt expense/(recoveries)	64,522	(18,175)
Amortization of debt discount and beneficial conversion feature	741,912	685,766
Interest expense on conversion of notes payable	93,931	3,464,187
Noncash expense recorded for settlement of royalty agreement (Note 5)		2,140,925
Loss on extinguishment of debt and disposal of assets	224,089	113,623
Loss on induced conversion of note payable	127,059
Gain on deconsolidation of subsidiary	(4,502,058)
Interest income receivable and amortization of discount on note receivable	(170,994)
Changes in operating assets and liabilities:
Accounts receivable	520,565	255,442
Prepaid expenses and other current assets	178,968	1,074,985
Decrease in deposits and other noncurrent assets		131,026
Inventory	343,911	(1,401,906)
Accounts payable	477,913	(155,164)
Accrued expenses	615,667	905,432
Indebtedness to related parties	476,661
Net cash used in operating activities of continuing operations	(3,003,570)	(7,399,899)
Net cash used in operating activities of discontinued operations	(1,244,721)	(447,852)
Net cash used in operating activities	(4,248,291)	(7,847,751)
INVESTING ACTIVITIES:
Purchase of property and equipment	(186,297)	(897,087)
Acquisition of intangible assets	(91,862)	(248,116)
Net cash used in investing activities of continuing operations	(278,159)	(1,145,203)
Net cash used in investing activities of discontinued operations	(260,625)	(8,946,434)
Net cash used in investing activities	(538,784)	(10,091,637)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrant exercises	1,860,200	8,823,555
Proceeds from notes payable and line of credit	2,960,000
Brokerage fees for issuance of common stock and warrants	(175,628)
Fees for issuance of convertible note	(175,000)
Principal payments on debt and finance lease obligations	(110,087)	(318,968)
Cash paid to settle royalty agreement		(1,000,000)
Net cash provided by financing activities of continuing operations	4,359,485	7,504,587
Net cash provided by financing activities of discontinued operations	282,835	7,179,156
Net cash provided by financing activities	4,642,320	14,683,743
Net change in cash and cash equivalents	(144,755)	(3,255,645)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	182,055	3,579,700
CASH AND CASH EQUIVALENTS AT END OF PERIOD	37,300	324,055
Less: cash and cash equivalents classified as discontinued operations		(236,283)
CASH AND CASH EQUIVALENTS AT END OF PERIOD FROM CONTINUING OPERATIONS	37,300	87,772
Cash paid for interest	451,040	539,242
Cash paid for income tax
Non-cash transactions:
Stock issued upon conversion of long-term note payable	525,000	4,640,971
Stock issued to settle royalty agreement		131,000
Depreciation capitalized in inventory	370,167	104,481
Induced dividend from warrant exercises	267,525	2,861,436
Property capitalized under operating leases	182,624
Cumulative effect of the new lease standard	7,550
Convertible Notes Payable [Member]
Non-cash transactions:
Beneficial conversion feature on notes payable	$ 829,736